Colchicine Prophylaxis When Using Intra‑articular Steroids for Acute Gout Flares

Recommendations from Guideline Societies

Add colchicine prophylaxis to intra‑articular corticosteroid therapy for an acute gout flare – the American College of Rheumatology (ACR) recommends this combination to prevent rebound flares. [1] [2] 3
The ACR explicitly endorses the use of intra‑articular steroids together with colchicine (strong recommendation). [4] [6]

Initial loading regimen: 1.2 mg colchicine followed 1 hour later by 0.6 mg on day 1. (Based on trial data). [1] [2] 4
Transition to prophylactic dosing: 0.6 mg once daily or twice daily thereafter. (Evidence from guideline‑based studies). [1] [5]
Length of prophylaxis: Continue colchicine for at least 6 months when starting urate‑lowering therapy, or for 3 months after achieving target serum urate in patients without tophi. (Long‑term outcome data). [1] [5] [3] [7]

Severe renal impairment (creatinine clearance < 30 mL/min): Reduce colchicine to 0.3 mg once daily or every other day. (Renal safety data). 1
Concurrent strong CYP3A4 inhibitors (e.g., clarithromycin, ketoconazole, ritonavir): Reduce to 0.3 mg once daily for prophylaxis. (Drug‑interaction studies). 1

Low‑dose NSAID plus proton‑pump inhibitor can be used as an alternative prophylactic regimen. (Guideline‑based recommendation). [1] [5]
Low‑dose prednisone (< 10 mg/day) is a second‑line option if colchicine cannot be used. (Evidence from comparative studies). [7] [5]

Fatal colchicine toxicity has been reported when combined with strong CYP3A4 inhibitors such as clarithromycin and with P‑glycoprotein inhibitors like cyclosporine. (Pharmacovigilance reports). 1
In patients on statins with renal impairment, there is an increased risk of neuromuscular toxicity from colchicine. (Observational safety data). [1] [5]

Do not inject corticosteroids if septic arthritis cannot be definitively excluded; aspiration and synovial fluid analysis are mandatory prior to injection. (EULAR and ACR safety guidance). [8] [9]
EULAR recommendation: Intra‑articular steroids should only be administered after an appropriate diagnosis has been confirmed and contraindications ruled out. (Strong guideline statement). 9
Risk of infection after steroid injection: Large‑joint intra‑articular steroid injections do not increase the absolute risk of septic arthritis (0.18 %); propensity‑matched analyses show no increased risk when aseptic technique is used. (Large cohort data). 9